248 related articles for article (PubMed ID: 26072124)
21. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
22. High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors.
Botling J; Lamarca A; Bajic D; Norlén O; Lönngren V; Kjaer J; Eriksson B; Welin S; Hellman P; Rindi G; Skogseid B; Crona J
Neuroendocrinology; 2020; 110(11-12):891-898. PubMed ID: 31658459
[TBL] [Abstract][Full Text] [Related]
23. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.
Young HT; Carr NJ; Green B; Tilley C; Bhargava V; Pearce N
J Clin Pathol; 2013 Aug; 66(8):700-4. PubMed ID: 23703851
[TBL] [Abstract][Full Text] [Related]
25. Grading Pancreatic Neuroendocrine Tumors by Ki-67 Index Evaluated on Fine-Needle Aspiration Cell Block Material.
Abi-Raad R; Lavik JP; Barbieri AL; Zhang X; Adeniran AJ; Cai G
Am J Clin Pathol; 2020 Jan; 153(1):74-81. PubMed ID: 31415691
[TBL] [Abstract][Full Text] [Related]
26. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
[TBL] [Abstract][Full Text] [Related]
27. Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essential.
van Velthuysen ML; Groen EJ; van der Noort V; van de Pol A; Tesselaar ME; Korse CM
Neuroendocrinology; 2014; 100(2-3):221-7. PubMed ID: 25358267
[TBL] [Abstract][Full Text] [Related]
28. Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors.
Goodell PP; Krasinskas AM; Davison JM; Hartman DJ
Am J Clin Pathol; 2012 Apr; 137(4):576-82. PubMed ID: 22431534
[TBL] [Abstract][Full Text] [Related]
29. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
[TBL] [Abstract][Full Text] [Related]
30. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
[TBL] [Abstract][Full Text] [Related]
31. Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors.
Wang HY; Li ZW; Sun W; Yang X; Zhou LX; Huang XZ; Jia L; Lin DM
Chin Med J (Engl); 2019 Mar; 132(5):551-561. PubMed ID: 30807354
[TBL] [Abstract][Full Text] [Related]
32. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors.
Laskiewicz L; Jamshed S; Gong Y; Ainechi S; LaFemina J; Wang X
Cancer Cytopathol; 2018 Mar; 126(3):170-178. PubMed ID: 29266776
[TBL] [Abstract][Full Text] [Related]
34. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
[TBL] [Abstract][Full Text] [Related]
35. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
36. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D; Viswanathan K; Goyal A; Rao R
Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
[TBL] [Abstract][Full Text] [Related]
37. The Influence of Tumor Stage on the Prognostic Value of Ki-67 Index and Mitotic Count in Small Intestinal Neuroendocrine Tumors.
Sun Y; Lohse C; Smyrk T; Hobday T; Kroneman T; Zhang L
Am J Surg Pathol; 2018 Feb; 42(2):247-255. PubMed ID: 29016403
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.
Weynand B; Borbath I; Bernard V; Sempoux C; Gigot JF; Hubert C; Lannoy V; Deprez PH; Jouret-Mourin A
Cytopathology; 2014 Dec; 25(6):389-95. PubMed ID: 24750272
[TBL] [Abstract][Full Text] [Related]
39. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
[TBL] [Abstract][Full Text] [Related]
40. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
